Nathalie Harroy
Net worth: 441 893 $ as of 2026-06-29
Net worth: 441 893 $ as of 2026-06-29
Nathalie Harroy worked as Chief Human Resources Officer at Abbott Laboratories Co. from 2010 to 2012.
Ms. Harroy worked as Head-Human Resources at Inventiva SA from 2012 to 2026.
Ms. Harroy worked as Senior Vice President-Research Division at Laboratoires Fournier SAS. Ms. Harroy completed undergraduate studies at Conservatoire National des Arts et Métiers.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INVENTIVA SA 0.05% | 2025-02-28 | 120,033 ( 0.05% ) | 441 893 $ | 2026-06-29 |
| Companies | Position | End |
|---|---|---|
| INVENTIVA | Human Resources Officer | 2026-04-21 |
Abbott Laboratories Co.
Abbott Laboratories Co. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional products, diagnostic tools and vascular devices | Human Resources Officer | 2011-12-31 |
Laboratoires Fournier SAS
Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Laboratoires Fournier SAS
Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Conservatoire National des Arts et Métiers
Conservatoire National des Arts et Métiers Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbott Laboratories Co.
Abbott Laboratories Co. Pharmaceuticals: MajorHealth Technology Manufactures and distributes nutritional products, diagnostic tools and vascular devices | Health Technology |
Inventiva SA
Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions